Invitae Corp.

( )
NVTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Medical Or Nursing Services
EVHCEnvision Healthcare Holdings, Inc.
DVADaVita HealthCare Partners Inc.
ACHCAcadia Healthcare Company, Inc.
CHEChemed Corporation
AMEDAmedisys, Inc.
LHCGLHC Group, Inc.
FMSFresenius Medical Care AG & Co. KGaA Sponsored ADR
ENSGEnsign Group, Inc.
AFAMAlmost Family, Inc.
USPHU.S. Physical Therapy, Inc.
RDNTRadNet, Inc.
NEONeoGenomics, Inc.
COChina Cord Blood Corporation
ADUSAddus HomeCare Corporation

Company Profile

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It provides diagnostic service comprising approximately 1,500 genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and whole exome analysis service. The company has created a genome network to connect patients, clinicians, advocacy organizations, researchers, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease. Invitae was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.